Daneng Li
Impact in
- Geriatrics and Gerontology top 0.5%
- Frailty in Older Adults
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 77
- Colorectal Cancer Treatments and Studies 22
- Pancreatic and Hepatic Oncology Research 22
- Lung Cancer Research Studies 16
- Cancer Immunotherapy and Biomarkers 16
- Epidemiology 29
- Neuroendocrine Tumor Research Advances 25
- Co-authors
- Arti Hurria (17 shared papers)Enrique Soto‐Pérez‐de‐Celis (12 shared papers)Wendy Verret (8 shared papers)Richard S. Finn (9 shared papers)Philippe Merle (9 shared papers)Peter R. Galle (8 shared papers)Masatoshi Kudo (9 shared papers)Ann‐Lii Cheng (9 shared papers)
- Journals
- Journal of Clinical Oncology (55 papers)Journal of Geriatric Oncology (9 papers)Cancers (8 papers)The Oncologist (3 papers)JCO Oncology Practice (3 papers)
- Partner nations
- United StatesSouth KoreaTaiwan
In The Last Decade
Daneng Li
128 papers receiving 3.7k citations
Daneng Li's Hit Papers
Peers
Comparison fields: 5 of 105
- Geriatrics and Gerontology 539
- Hepatology 1.0k
- Oncology 1.2k
- Pathology and Forensic Medicine 300
- Surgery 674
Countries citing papers authored by Daneng Li
This map shows the geographic impact of Daneng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daneng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daneng Li more than expected).
Fields of papers citing papers by Daneng Li
This network shows the impact of papers produced by Daneng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daneng Li. The network helps show where Daneng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Daneng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma Hit paper breakdown → | 2021 | 967 |
| 2 | A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer Hit paper breakdown → | 2020 | 320 |
| 3 | 2018 | 272 | |
| 4 | Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer Hit paper breakdown → | 2021 | 267 |
| 5 | IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC). Hit paper breakdown → | 2021 | 239 |
| 6 | 2007 | 116 | |
| 7 | 2009 | 107 | |
| 8 | 2020 | 71 | |
| 9 | 2019 | 70 | |
| 10 | 2020 | 64 | |
| 11 | 2019 | 57 | |
| 12 | 2018 | 54 | |
| 13 | 2018 | 51 | |
| 14 | 2021 | 45 | |
| 15 | 2023 | 43 | |
| 16 | 2021 | 40 | |
| 17 | 2004 | 37 | |
| 18 | 2015 | 33 | |
| 19 | 2018 | 32 | |
| 20 | 2019 | 32 |
About Daneng Li
Daneng Li is a scholar working on Oncology, Epidemiology, Hepatology, Surgery and Pulmonary and Respiratory Medicine, having authored 142 papers that have together received 3.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Neuroendocrine Tumor Research Advances (25 papers), Colorectal Cancer Treatments and Studies (22 papers), Pancreatic and Hepatic Oncology Research (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Lung Cancer Research Studies (16 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Frailty in Older Adults (14 papers). The work is most often cited by research in Geriatrics and Gerontology (539 citations), Hepatology (1.0k citations), Oncology (1.2k citations), Pathology and Forensic Medicine (300 citations) and Surgery (674 citations). Daneng Li has collaborated with scholars based in United States, South Korea and Taiwan. Frequent co-authors include Arti Hurria, Enrique Soto‐Pérez‐de‐Celis, Wendy Verret, Richard S. Finn, Philippe Merle, Peter R. Galle, Masatoshi Kudo, Ann‐Lii Cheng, В. В. Бредер and Andrew X. Zhu. Their work appears in journals such as Journal of Clinical Oncology, Journal of Geriatric Oncology, Cancers, The Oncologist and JCO Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.